EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genomic analysis of invasive and non-invasive disease-causing Streptococcus pneumoniae isolated from children between 2014 and 2023 in Suzhou, China

Lili Huang, Alannah C King, Yue Liu, Harry C H Hung, Stephen D Bentley, Yue Jiang, Panpan Lv, Xuebin Xu, Stephanie W Lo, Mingliang Chen

Microbial Genomics · 2025

DOI: 10.1099/mgen.0.001398 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Genomics, 2025. Verfasst von Lili Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Department, Children's Hospital of Soochow University, Suzhou, Jiangsu, PR China. Hauptthemen laut MEDLINE: Streptococcus pneumoniae, Pneumococcal Infections. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Gates Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In 2017, 553,000 clinical cases of Streptococcus pneumoniae in children were reported in China, although the pneumococcal conjugate vaccine (PCV), which targets the pneumococcal capsule, is not included in the Chinese National Immunization Program (NIP) for children. Therefore, the PCV uptake rate is very low. To investigate the S. pneumoniae population over the past 10 years in China, we collected 418 S. pneumoniae isolates from children with pneumococcal diseases in Suzhou, China, 2014–2023, and whole-genome sequenced them. A total of 27 serotypes expressed by 36 Global Pneumococcal Sequence Clusters (GPSCs) that encompassed 72 sequence types were identified, with serotype 19F (38.3%, n =160) and GPSC1 (60.8%, n =254) as the predominant serotype and lineage, respectively. We found that the majority (64.8%, n =271) of samples represented serotypes that are covered by the GSK 10-valent PCV (PCV10) formulation and that even more were covered by the SII PCV10 formulation (89.2%, n =373). Almost all (94.3%, n =394) samples represented serotypes that are included within the 13-valent PCV (PCV13) vaccine formulation. This suggests that the inclusion of the PCV in the NIP would lead to significant benefits for child health. Also, we observed that no significant differences were seen in the serotypes or lineages in cases of invasive and non-invasive pneumococcal diseases.Additionally, we investigated the prevalence of antimicrobial resistance within the population and found that 99.8% ( n =417) of isolates were predicted to be resistant to at least one antibiotic tested. This again supports the need to increase PCV uptake to prevent infections with antibiotic-resistant S. pneumoniae and to reduce the number of infections in general, consequently lowering the consumption of antibiotics. In summary, the PCV13 vaccine could potentially cover over 90% of invasive and non-invasive S. pneumoniae isolates in Suzhou, China. Therefore, increasing the uptake of PCVs by including PCV13 in the NIP would lead to significant benefits for child health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Streptococcus pneumoniaePneumococcal InfectionsHumansChinaPneumococcal VaccinesChild, PreschoolSerogroupChildInfantWhole Genome SequencingGenome, BacterialGenomicsAnti-Bacterial AgentsMaleFemale

Stichwörter der Autor:innen

Global Pneumococcal Sequencing projectStreptococcus pneumoniaeinvasivemultidrug resistancepneumococcal conjugate vaccine (PCV)

Substanzen

Pneumococcal VaccinesAnti-Bacterial Agents

Autor:innen und Institutionen

  • Laboratory Department, Children's Hospital of Soochow University, Suzhou, Jiangsu, PR China.
  • Parasites and Microbes, The Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
  • Department of Microbiology, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, PR China.
  • Research and Translational Laboratory of Acute Injury and Secondary Infection and Department of Laboratory Medicine, Minhang Hospital, Fudan University, Shanghai, PR China.
  • Milner Centre for Evolution, Department of Life Sciences, University of Bath, Bath, UK.
  • The Great Ormond Street Institute of Child Health, University College London, London, UK.

Förderung

  • Wellcome Trust
  • Gates Foundation
  • National Natural Science Foundation of China
  • Bill & Melinda Gates Foundation

Zitieren

APA

Huang, L., King, A. C., Liu, Y., Hung, H. C. H., Bentley, S. D., Jiang, Y., Lv, P., Xu, X., Lo, S. W., & Chen, M. (2025). Genomic analysis of invasive and non-invasive disease-causing Streptococcus pneumoniae isolated from children between 2014 and 2023 in Suzhou, China. Microbial Genomics. https://doi.org/10.1099/mgen.0.001398

Vancouver

Huang L, King AC, Liu Y, Hung HCH, Bentley SD, Jiang Y, et al. Genomic analysis of invasive and non-invasive disease-causing Streptococcus pneumoniae isolated from children between 2014 and 2023 in Suzhou, China. Microbial Genomics. 2025. doi:10.1099/mgen.0.001398

BibTeX
@article{Huang2025,
  author = {Huang, Lili and King, Alannah C and Liu, Yue and Hung, Harry C H and Bentley, Stephen D and Jiang, Yue and Lv, Panpan and Xu, Xuebin and Lo, Stephanie W and Chen, Mingliang},
  title = {Genomic analysis of invasive and non-invasive disease-causing Streptococcus pneumoniae isolated from children between 2014 and 2023 in Suzhou, China},
  journal = {Microbial Genomics},
  year = {2025},
  doi = {10.1099/mgen.0.001398}
}
Kostenlos starten →